{"id":273134,"date":"2023-12-09T19:44:01","date_gmt":"2023-12-09T14:14:01","guid":{"rendered":"https:\/\/forumias.com\/blog\/?p=273134"},"modified":"2023-12-09T19:44:01","modified_gmt":"2023-12-09T14:14:01","slug":"lyfgenia-and-casgevy-u-s-fda-approves-gene-therapies-for-sickle-cell-disease","status":"publish","type":"post","link":"https:\/\/forumias.com\/blog\/lyfgenia-and-casgevy-u-s-fda-approves-gene-therapies-for-sickle-cell-disease\/","title":{"rendered":"Lyfgenia and Casgevy: U.S FDA approves gene therapies for sickle cell disease"},"content":{"rendered":"<p><b>Source: <\/b><span style=\"font-weight: 400;\">The post is based on the article <\/span><b>\u201c<\/b><b>Lyfgenia and Casgevy: <\/b><b>U.S FDA approves gene therapies for sickle cell disease<\/b><b>\u201d <\/b><span style=\"font-weight: 400;\">published in<\/span><b> \u201cThe Hindu\u201d on 9th December 2023<\/b><\/p>\n<h2>Why in the News?<\/h2>\n<p><span style=\"font-weight: 400;\">The U.S Food and Drug Administration (FDA) has approved a pair of gene therapies named Lyfgenia and Casgevy for the treatment of sickle cell disease.<\/span><\/p>\n<h2>What is Lyfgenia?<\/h2>\n<table>\n<tbody>\n<tr>\n<td><b>Specifications<\/b><\/td>\n<td><b>Details<\/b><\/td>\n<\/tr>\n<tr>\n<td><b>What is it<\/b><\/td>\n<td><span style=\"font-weight: 400;\">Lyfgenia is a <\/span><span style=\"font-weight: 400;\">cell-based gene therapy developed for the treatment of sickle cell disease.<\/span><\/td>\n<\/tr>\n<tr>\n<td><b>Developed by\u00a0<\/b><\/td>\n<td><span style=\"font-weight: 400;\">Bluebird Bio\u00a0<\/span><\/td>\n<\/tr>\n<tr>\n<td><b>Eligibility<\/b><\/td>\n<td><span style=\"font-weight: 400;\">The therapy is <\/span><span style=\"font-weight: 400;\">approved for people aged 12 years and older.<\/span><\/td>\n<\/tr>\n<tr>\n<td><b>Treatment process<\/b><\/td>\n<td><span style=\"font-weight: 400;\">1) <\/span><span style=\"font-weight: 400;\">The treatment involves removing stem cells out of bone marrow from a patient\u2019s blood.<br \/>\n<\/span><span style=\"font-weight: 400;\">2) The <\/span><span style=\"font-weight: 400;\">stem cells are then genetically modified to produce HbAT87Q. It is a gene-therapy-derived haemoglobin that functions similarly to haemoglobin A or the normal adult haemoglobin produced by those who do not have sickle cell disease.<br \/>\n<\/span><span style=\"font-weight: 400;\">3) The modified stem cells are then delivered to the patient in a one-time, single-dose infusion.<\/span><span style=\"font-weight: 400;\">\u00a0<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>What is Casgevy?<\/h2>\n<p><a href=\"https:\/\/forumias.com\/blog\/casgevy-how-gene-therapy-will-revolutionize-treatment-of-sickle-cell-disease\/\"><b>Click Here to read<\/b><\/a><\/p>\n<h2>What is Sickle Cell Disease?<\/h2>\n<p>1) It is a genetic <strong>red blood cell disorder that affects the shape of the hemoglobin<\/strong>, a protein that carries oxygen through the body.<\/p>\n<p>2) The RBCs become <strong>crescent- or \u201csickle\u201d-shaped <\/strong>which makes the flow of hemoglobin through the blood vessels difficult, <strong>blocking the blood flow\u00a0to the rest of the body.<\/strong><\/p>\n<p><strong>UPSC Syllabus: Science and Technology<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Source: The post is based on the article \u201cLyfgenia and Casgevy: U.S FDA approves gene therapies for sickle cell disease\u201d published in \u201cThe Hindu\u201d on 9th December 2023 Why in the News? The U.S Food and Drug Administration (FDA) has approved a pair of gene therapies named Lyfgenia and Casgevy for the treatment of sickle&hellip; <a class=\"more-link\" href=\"https:\/\/forumias.com\/blog\/lyfgenia-and-casgevy-u-s-fda-approves-gene-therapies-for-sickle-cell-disease\/\">Continue reading <span class=\"screen-reader-text\">Lyfgenia and Casgevy: U.S FDA approves gene therapies for sickle cell disease<\/span><\/a><\/p>\n","protected":false},"author":10317,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"categories":[1566,1738],"tags":[11872],"class_list":["post-273134","post","type-post","status-publish","format-standard","hentry","category-daily-factly-articles","category-science-and-technology-daily-factly-articles","tag-9pm-daily-factly","entry"],"jetpack_featured_media_url":"","views":{"total":11,"cached_at":"","cached_date":1702157346},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/273134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/users\/10317"}],"replies":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/comments?post=273134"}],"version-history":[{"count":0,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/posts\/273134\/revisions"}],"wp:attachment":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/media?parent=273134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/categories?post=273134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/tags?post=273134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}